Coagulation disorders in pregnancy: Acquired and inherited thrombophilias

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 106-117

  Benedetto, Chiara ^a   Marozio, Luca ^a   Tavella, Anna Maria ^a   Salton, Loredana ^a   Grivon, Sara ^a   Di Giampaolo, Francesca ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

acquired thrombophilia; adverse pregnancy outcome; deep venous thrombosis; inherited thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACQUIRED THROMBOPHILIA; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITED THROMBOPHILIA; INTRAUTERINE GROWTH RETARDATION; LUNG EMBOLISM; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; SCREENING TEST; SOLUTIO PLACENTAE; THROMBOPHILIA; BLOOD COAGULATION DISORDERS; COMPLICATION; FETAL GROWTH RETARDATION; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

BLOOD COAGULATION DISORDERS; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 77957031299     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05674.x     Document Type: Conference Paper

References (67)

1. Middledorp, S. & M. Levi. 2007. Thrombophilia: an update. Semin. Thromb. Hemost. 33: 563-572.
2. Pabinger, I. 2009. Thrombophilia and its impact on pregnancy. Thromb. Res. 123(Suppl. 3): S16-S21.
3. Wilson, W.A., A.E. Gharavi, T. Koike, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42: 1309-1311.
4. Miyakis, S., M.D. Lockshin, T. Atsumi, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4: 295-306.
5. DCruz, D.P., M.A. Khamashta & G.R. Hughes. 2007. Systemic lupus erythematosus. Lancet 369: 587-596.
6. Crowther, M.A. & J.G. Kelton. 2003. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann. Intern. Med. 138: 128-134.
7. Buchanan, G.S., G.M. Rodgers & D.W. Branch. 2003. The inherited thrombophilias: genetics, epidemiology, and laboratory evaluation. Best Pract. Res. Clin. Obstet. Gynecol. 17: 397-411.
8. Franco, R.M. & P.H. Reitsma. 2001. Genetic risk factors of venous thrombosis. Hum. Genet. 109: 369-384.
9. De Stefano, V., E. Rossi, K. Paciaroni & G. Leone. 2002. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 87: 1095-1108.
10. Dizon-Thownson, D., C. Miller, B. Sibai, et al. 2005. The relationship of Factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet. Gynecol. 106: 517-524.
11. Rees, D.C., M. Cox & J.B. Clegg. 1995.World distribution of factot V Leiden. Lancet 346: 1133-1134.
12. Rosendaal, F.R., C.J. Doggen, A. Zivelin, et al. 1998. Geographic distribution of the 20210 G to A prothrombin variant. Thromb. Haemost. 79: 706-708.
13. Ronsmans, C. & W.J. Graham. 2006. Maternal mortality: who, when, where, and why. Lancet 368: 1189-1200.
14. CEMACH. Saving mothers lives: reviewing maternal deaths to make motherhood safer-2003-2005. The seventh report of the Confidential Enquiry into Maternal Deaths in the United Kingdom. December 2007.
15. James, A.H., M.G. Jamison, L.R. Brancazio, et al. 2006. Venous thromboembolism during pregnancy and the postpartum: incidence, risk factors, and mortality. Am. J. Obstet. Gynecol. 194: 1311-1315.
16. Pomp,E.R., A.M. Lenselink, F.R.Rosendaal, et al. 2008.Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J. Thromb. Haemost. 6: 632-637.
17. Ray, J.G. & W.S. Chan. 1999. Deep vein thrombosis during pregnancy and the puerperium: ameta-analysis of the period of risk and leg of presentation.Obstet.Gynecol. Surv. 54: 254-271.
18. Simpson, E.L., R.A. Lawrenson, A.L. Nightingale, et al. 2001.Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Br. J. Obstet. Gynaecol. 108: 56-60.
19. Pabinger, I., H. Grafenhofer, P.A. Kyrle, et al. 2002. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 100: 1060-1062.
20. Brill-Edwards, P., J.S. Ginsberg, M. Gent, et al. 2000. Recurrence of Clot in This Pregnancy Study Group. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N. Engl. J. Med. 343: 1439-1444.
21. Pabinger, I., H. Grafenhofer, A. Kaider, et al. 2005. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J. Thromb. Haemost. 3: 949-954.
22. De Stefano, V., I.Martinelli, E. Rossi, et al. 2006. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br. J. Haematol. 135: 386-391.
23. Sanson, B.J., A.W. Lensing, M.H. Prins, et al. 1999. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb. Haemost. 81: 668-672.
24. Leperq, J., J. Conard, A. Borel-Derlon, et al. 2001. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. Br. J. Obstet. Gynaecol. 108: 1134-1140.
25. Robertson, L., O. Wu, P. Langhorne, et al. 2005. Thrombophilia in pregnancy: a systematic review. Br. J. Haematol. 132: 171-196.
26. Gerhardt, A., R.E. Scharf, M.W. Beckman, et al. 2000. Prothrombin and factorVmutations inwomenwith thrombosis during pregnancy and the puerperium.N. Engl. J. Med. 342: 374-380.
27. McColl,M., J.E. Ramsay,R.C.Tait, et al. 1997. Risk factors forpregnancy associated venous thromboembolism. Thromb. Haemost. 8: 1183-1188.
28. Long, A.A., J.S. Ginsberg, P. Brill-Edwards, et al. 1991. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a crosssectional study. Thromb. Haemost. 66: 520-524.
29. Greer, I.A. 2000. The challenge of thrombophilia in maternal-fetal medicine. N. Engl. J. Med. 342: 424-425.
30. Greer, I.A.&C.Nelson-Piercy. 2005. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106: 401-407.
31. Bates, S.M., I.A. Greer, I. Pabinger, et al. 2008. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest 133: 844S-886S.
32. Italian Society for the Study of Haemostasis and Thrombosis. Thrombophilia screening and indications for pharmacologic prophylaxis in pregnancy. SISET Guidelines, May 2008. Available at: www.siset.it .
33. American College of Obstetricians and Gynecologists. 2001. Thromboembolism in pregnancy. ACOG Practice Bulletin No. 19. Int. J. Gynaecol. Obstet. 2001. 75: 203-212.
34. Royal College of Obstetricians and Gynaecologists. 2009. Thrombosis and embolism during pregnancy and the puerperium, reducing the risk. RCOG Green-top guideline No. 37.
35. Guyatt,G.,D.Gutterman,M.H. Baumann, et al. 2006.Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Phisicians Task Force. Chest 129: 174-181.
36. Alfirevic, Z., D. Roberts & V. Martlew. 2002. How strong is the association between maternal thrombophilia and adverse pregnancy outcome?Asystematic review. Eur. J.Obstet. Gynecol. Reprod. Biol. 101: 6-14.
37. Rey, E., S.R. Kahn, M. David, et al. 2003. Thrombophilic disorders and fetal loss: a metaanalysis. Lancet 362: 901-908.
38. Robertson, L., O. Wu, P. Langhorne, et al. 2006. for The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study: thrombophilia in pregnancy; a systematic review. Br. J. Haematol. 132: 171-196.
39. Zupan, J.&E.Aahman. 2005. Perinatalmortality for the year 2000: estimates developed by WHO. Geneva, World Health Organization.
40. Sondheimer, S. 1999. Abortion. Encycl Reprod. 1: 1-6.
41. Hatasaka, H.H. 1994. Recurrent miscarriage epidemiologic factors, definitions, and incidence. Clin. Obstet. Gynecol. 37: 625-634.
42. Facchinetti, F., U. Reddy, B. Stray-Pedersen, et al. on behalf the Stillbirth International Group. 2008. International issues on stillbirth. J. Matern. Fetal Neonatal Med. 21: 425-428.
43. Lissalde-Lavigne, G., P. Fabbro-Peray, E. Cochery- Nouvellon, et al. 2005. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched casecontrol NOHA first study. J. Thromb. Haemost. 3: 2178-2184.
44. Harris, E.N. 1987. Syndrome of the black swan. Br. J. Rheumatol. 26: 324-326.
45. Cervera, R., J.C. Piette & J. Font. 2002. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 46: 1019-1027.
46. Levine, J.S., D.W. Branch & J. Rauch. 2002. The antiphospholipid syndrome. N. Engl. J. Med. 346: 752-763.
47. Vinatier,D., P. Dufour,M.Cosson&J.L.Houpeau. 2001.Antiphospholipid syndrome and recurrentmiscarriages. Eur. J. Obstet. Gynaecol. Reprod. Biol. 96: 37-50.
48. Chauleur, C., J.P. Galanaud, S. Alonso, et al. 2010. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J. Thromb. Haemost. 8: 699-706.
49. Di Simone, N., P.L. Meroni, N. Del Papa, et al. 2000. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein 1. Arthritis Rheum. 43: 140-150.
50. Martinelli, I., E. Taioli, I. Cetin, et al. 2000. Mutations in coagulation factors in women with unexplained late fetal loss.N. Engl. J. Med. 343: 1015-1018.
51. Dizon-Townson, D., C. Miller, B. Sibai, et al. 2005. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet. Gynecol. 106: 517-524.
52. Kist,W.J., N.G. Janssen, J.J.Kalk, et al. 2008. Thrombophilias and adverse pregnancy outcome-a confounded problem. Thromb. Haemost. 99: 77-85.
53. Howley,H.E., M.Walker &M.A. Rodger. 2005. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am. J. Obstet. Gynecol. 192: 694-708.
54. Facchinetti, F., L.Marozio, E. Grandone, et al. 2003. Thrombophilicmutations are amain risk factor for placental abruption. Haematologica 88: 785-788.
55. Kujovich, J.L. 2004. Thrombophilia and pregnancy complications. Am. J. Obstet. Gynecol. 191: 412-424.
56. Morrison, E.R., Z.H.Miedzybrodzka, D.M. Campbell, et al. 2002. Prothrombotic genotypes are not associated with preeclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb. Haemost. 87: 779-785.
57. Livingston, J.C., J.R. Barton, V. Park, et al. 2001. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am. J. Obstet. Gynecol. 85: 153-157.
58. Duckitt, K. & D. Harrington. 2005. Risk nfactors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 330: 565-572.
59. Clark, E.A., R.M. Silver & D.W. Branch 2007. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr. Rheumatol. Rep. 9: 219-225.
60. Benedetto, C., L. Marozio, L. Salton, et al. 2002. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet. Gynecol. Scand. 81: 1095-1100.
61. Mello, G., E. Parretti, L.Marozio, et al. 2005. Thrombophilia is significantly associatedwith severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46: 1270-1274.
62. Facchinetti, F., L. Marozio, T. Frusca, et al. 2009. Maternal thrombophilia and the risk of recurrence of preeclampsia. Am. J. Obstet. Gynecol. 200: 46e.1-46e.5.
63. Empson, M., M. Lassere, J. Craig, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst. Rev. 2005.
64. Noble, L.S., W.H. Kutteh, N. Lashey, et al. 2005. Antiphospholipi antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatmentwith lowmolecular-weight heparin versus unfractionated heparin. Fertil. Steril. 83: 684-690.
65. Stephenson, M.D., P.J. Ballem, P. Tsang, et al. 2004. Treatment of antiphospholipid antibodies syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular-weight heparin to unfractionated heparin. J. Obstet. Gynaecol. Can. 26: 729-734.
66. Duley, L., D.J. Henderson-Smart, M. Knight, et al. AAntiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev. 2007.
67. Wu, O., L. Robertson, S. Twaddle, et al. 2006. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The TREATS study. Health Technol. Assess. 10: 1-110.